Redwood Investment Management, LLC Ironwood Pharmaceuticals Inc Transaction History

Redwood Investment Management, LLC

$1.13 Billion
Q3 2024

A detailed history of Redwood Investment Management, LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Redwood Investment Management, LLC holds 534,560 shares of IRWD stock, worth $1.89 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

534,560

Previous 475,777 12.36%

Holding current value

$1.89 Million

Previous $2.86 Million 24.83%

% of portfolio

0.19%

Previous 0.25%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.93 - $7.04 $231,017 - $413,832	58,783 Added 12.36%	534,560 $2.15 Million
Q2 2024 Aug 14, 2024	BUY	$5.58 - $8.61 $608,699 - $939,230	109,086 Added 29.75%	475,777 $2.86 Million
Q1 2024 May 15, 2024	BUY	$8.32 - $15.45 $699,479 - $1.3 Million	84,072 Added 29.75%	366,691 $3.19 Million
Q4 2023 Feb 14, 2024	SELL	$8.79 - $11.51 $414,782 - $543,133	-47,188 Reduced 14.31%	282,619 $3.23 Million
Q3 2023 Nov 14, 2023	SELL	$8.25 - $11.35 $419,586 - $577,249	-50,859 Reduced 13.36%	329,807 $3.18 Million
Q2 2023 Aug 14, 2023	BUY	$10.1 - $11.6 $480,477 - $551,835	47,572 Added 14.28%	380,666 $3.76 Million
Q1 2023 May 15, 2023	BUY	$10.37 - $12.56 $910,983 - $1.1 Million	87,848 Added 35.82%	333,094 $3.5 Million
Q3 2022 Nov 14, 2022	BUY	$10.14 - $12.38 $89,313 - $109,043	8,808 Added 3.73%	245,246 $2.54 Million
Q2 2022 Aug 15, 2022	BUY	$11.05 - $12.72 $134,655 - $155,005	12,186 Added 5.43%	236,438 $2.73 Million
Q1 2022 May 16, 2022	BUY	$10.61 - $12.88 $346,214 - $420,287	32,631 Added 17.03%	224,252 $2.82 Million
Q4 2021 Feb 14, 2022	BUY	$10.86 - $13.95 $375,169 - $481,916	34,546 Added 21.99%	191,621 $2.23 Million
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $187,382 - $218,822	15,720 Added 11.12%	157,075 $2.05 Million
Q2 2021 Aug 17, 2021	BUY	$10.16 - $13.11 $93,370 - $120,480	9,190 Added 6.95%	141,355 $1.82 Million
Q1 2021 May 18, 2021	SELL	$9.04 - $11.86 $225,331 - $295,622	-24,926 Reduced 15.87%	132,165 $1.48 Million
Q1 2021 May 17, 2021	BUY	$9.04 - $11.86 $526,263 - $690,429	58,215 Added 58.88%	157,091 $1.76 Million
Q4 2020 Feb 16, 2021	SELL	$9.05 - $12.2 $240,404 - $324,080	-26,564 Reduced 21.18%	98,876 $1.13 Million
Q3 2020 Nov 16, 2020	BUY	$8.99 - $10.74 $241,372 - $288,358	26,849 Added 27.23%	125,440 $1.13 Million
Q2 2020 Aug 14, 2020	BUY	$9.14 - $11.97 $170,497 - $223,288	18,654 Added 23.34%	98,591 $1.02 Million
Q1 2020 May 13, 2020	SELL	$8.58 - $14.01 $85,225 - $139,161	-9,933 Reduced 11.05%	79,937 $807,000
Q4 2019 Feb 14, 2020	SELL	$8.22 - $14.0 $273,660 - $466,088	-33,292 Reduced 27.03%	89,870 $1.2 Million
Q3 2019 Nov 18, 2019	BUY	$8.59 - $10.96 $1.06 Million - $1.35 Million	123,162 New	123,162 $1.06 Million
Q2 2019 Aug 15, 2019	SELL	$9.8 - $12.89 $935,047 - $1.23 Million	-95,413 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$9.8 - $12.89 $935,047 - $1.23 Million	95,413 New	95,413 $1.04 Million

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redwood Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redwood Investment Management, LLC with notifications on news.

Account

Redwood Investment Management, LLC Ironwood Pharmaceuticals Inc Transaction History